A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome

NCT02682927 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

262

Enrollment

INDUSTRY

Sponsor class

Conditions

Dravet Syndrome
Seizure Disorder

Interventions

DRUG: ZX008 (Fenfluramine Hydrochloride)
DRUG: Matching Placebo

Sponsor

Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.